37
DKA ICP February 2005 Reviewed May 2018 Version 7 1 Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS (DKA) Details Ward: Consultant: Named Nurse: Date of Admission: Date of Discharge/Transfer: ALL STAFF TO WRITE IN BLACK INK WITHIN THE PATHWAY. DOCTORS WRITE AGAINST GREEN TEXT, NURSES AGAINST BLACK TEXT Doctors /Diabetes Specialist Nurse Green Nurses: Black Therapists: Red ALL STAFF WRITING IN THIS ICP SHOULD GIVE A SAMPLE SIGNATURE BELOW Name (print) Position Sample Signature Initials Definition Diabetic Ketoacidosis Adapted ISPAD Consensus guidelines/BSPED guidelines for the management of type 1 diabetes mellitus in children and adolescents 1. Hyperglycaemia (Blood glucose (BG) >11 mmol/L) 2. pH <7.3 3. Bicarbonate <18 mmol/L 4. Blood ketones (near patient testing method)>3.0 mmol/l MILD/MODERATE DKA – pH >7.1 SEVERE DKA – pH <7.1 Patient Label

Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

1

Integrated Care Pathway

PAEDIATRIC DIABETIC KETOACIDOSIS (DKA)

Details Ward: Consultant: Named Nurse: Date of Admission: Date of

Discharge/Transfer:

ALL STAFF TO WRITE IN BLACK INK WITHIN THE PATHWAY. DOCTORS WRITE AGAINST GREEN TEXT, NURSES AGAINST BLACK TEXT

Doctors /Diabetes Specialist Nurse Green Nurses: Black Therapists: Red ALL STAFF WRITING IN THIS ICP SHOULD GIVE A SAMPLE SIGNATURE BELOW

Name (print)

Position

Sample Signature

Initials

Definition Diabetic Ketoacidosis

Adapted ISPAD Consensus guidelines/BSPED guidelines for the management of type 1 diabetes mellitus in children and adolescents

1. Hyperglycaemia (Blood glucose (BG) >11 mmol/L) 2. pH <7.3 3. Bicarbonate <18 mmol/L 4. Blood ketones (near patient testing method)>3.0 mmol/l

MILD/MODERATE DKA – pH >7.1 SEVERE DKA – pH <7.1

Patient Label

Page 2: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

Clinical history Polyuria

Polydipsia Weight loss

Abdominal pain Tiredness Vomiting

Confusion

Clinical signs Assess dehydration

Deep sighing respiration (kaussmaul) Smell of ketones

Lethargy/drowsiness and vomiting

Biochemistry Elevated blood glucose

Acidaemia Ketones in blood & urine

Take blood for U&E and HbA1C Other investigations if first

presentation

Diagnosis confirmed DIABETIC KETOACIDOSIS

Contact senior staff

Shock Reduced peripheral pulse volume Reduced conscious level Coma,

Clinically dehydrated Vomiting or nauseated

Not alert

Resuscitation Airway/nasogastric tube

Breathing (100% O2) Circulation 0.9% NaCl 10mL/kg

over 10-30 minutes until circulation restored.

(Max one dose before discussion with senior doctor)

IV Therapy Calculate fluid requirements correct deficit over 48 hours

0. 9% NaCl with KCl 40 mmol/L

insulin 0.05Units/kg/hour by infusion 1 hour after starting iv fluids

Continue SC Lantus/Levemir if known diabetic Stop insulin pump if on pump therapy

Critical observations Hourly blood glucose 2-4 hourly blood gas

Hourly fluid input / output Neurological status at least hourly

Electrolytes at least two hourly after start of IV therapy 1-2 hourly blood ketones

Monitor ECG for T wave changes

Acidosis not improving

Neurological deterioration Warning signs Headache, slowing heart rate, irritability, decreased conscious level, incontinence, rapid fall in serum sodium > 5mmol/hour

Re-evaluat e Fluid balance and IV therapy (calculations) If continued acidosis may require further resuscitation fluid Check Insulin delivery systems and dose Consider sepsis

IV therapy 1.If Ketones ≤3 mmol/L continue insulin at 0.05 U/kg/h. Change to 0.9% NaCl + 5% dextrose with KCl40mmol/L 2. If ketones > 3 mmol/L consider Increasing insulin to 0.1 units/kg/h and then change to 0.9% NaCl + 10% dextrose with KCl 40 mmol/L (Discuss with Consultant)

Exclude Hypoglycaemia Is it cerebral oedema?

Improvement Clinically well, tolerating oral fluids

pH normal (> 7.3) and blood ketones reducing

- Discuss with consultant

Transition to SC insulin /pump -Start SC insulin then

Stop IV insulin one hour later

Management -give 5 ml/kg 2.7% Saline or Mannitol 0.5 – 1 g/kg -call senior staff -restrict I.V. fluids by 1/2 -Nurse 15 ° head up -move to ITU - CT Scan when stabilised

change to 0.9% NaCl + 10% dextrose with KCl 40 mmol/L

If Blood glucose ≤ 6mmol/L

Blood glucose 6-14 mmol/L

-

ALGORITHM FOR THE MA NAGEMENT OF DIABETIC KETOACIDOSIS IMMEDIATE ASSESSMENT

Page 3: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

CEREBRAL OEDEMA

This is a medical emergency. Once suspected it shou ld be treated immediately. Call for senior help .

Background Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis. It can occur any time up to 24 hours after the start of resuscitation. It can be present at the presentation of DKA. One of the most important principles of management is the slow correction of biochemical abnormalities. This will help prevent the development of cerebral oedema.

Risk Factors • Young age (< 5 years) • Adolescents • pCO2 < 2 kPa at presentation • pH < 7.1 at presentation • > 40mL/kg IV Fluid in first 4 hours • Rapid falls in corrected Sodium (> 5 mmol/L/hour) • NaHCO3 therapy • Raised serum urea • Hyperventilation post-intubation

Symptoms

• Headache • Impaired level of consciousness • Confusion • Convulsions • Irritability • Incontinence

Signs

• Hypertension • Bradycardia • Low saturations • Change in neurological status • Focal neurology • Abnormal posturing • Seizures

Management

• Increase frequency of neurological observations to every 15 minutes • Exclude hypoglycaemia • Give 5 mL/kg of 2.7% NaCl over 5 – 10 minutes (this is kept on Ash Ward and in A&E) • Restrict fluids to 50% maintenance and replace the deficit over 72 hours • Nurse at 15° head up and keep head in midline • Call anaesthetists as may need intubation and ventilation • Liaise with PICU • Consider cranial imaging if patient stabilises • Careful documentation in notes

Page 4: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

USE ADDRESSOGRAPH LABEL IF AVAILABLE

NAME: Age & Sex:

ADDRESS: Phone No:

GP & Surgery:

GP phone no:

Admitting Consultant:

Date of birth: Source & Type of Referral:

Hospital Number: Information obtained from:

DATE & TIME OF INTERVIEW: PRESENTING COMPLAINT(S):

HISTORY OF PRESENTING COMPLAINT(S):

Continue on page 6 if necessary PAST MEDICAL HISTORY: FAMILY HISTORY:

PERINATAL HISTORY Delivery Type: Neonatal Problems: DRUG HISTORY/ALLERGIES

IMMUNISATIONS: Other Any Problems:

DEVELOPMENTAL HISTORY EDUCATION (School / Nursery)

Page 5: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

5

PATIENT LABEL

PHYSICAL EXAMINATION: Weight: kg

HR

BP

RR

O2 sats

Temp

Capillary refill time

Capillary blood glucose

Blood ketones

Glasgow coma score:

% Dehydration

Time Assessment / Observations Sign Reason for variance & action taken Sign

Airway protected

Oxygen given 100% via face mask

Maintain NBM until assessed

Consider NG tube

IV access obtained x 2 IV cannulas in situ, and secured position

Cardiac monitor (consider T wave changes)

Consider urinary catheter

Commence ½ hourly recordings of B/P pulse and respiratory rate

1-2 hourly recordings of temperature

Hourly fluid balance of input &output

DATE……./……/…….

Page 6: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

6

PATIENT LABEL

Record GCS

� ¼ hrly for 1st hour � ½ hrly for next hour � 1 hrly thereafter

Page 7: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION SIGN

Page 8: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

8

PATIENT LABEL

ADMISSION DAY IMMEDIATE MANAGEMENT DATE……./……./…… .

Time Initial treatment Sign Reason for variance & action taken Sign

Calculate fluid requirements

Prescribe fluids as per requirements

If shock is present 0.9% NaCl 10 mL/kg over 10-30 minutes.

No more than 1 bolus unless discussed with Consultant.

FLUID REQUIREMENT = DEFICIT + MAINTENANCE

The calculation of deficit is specific for the mana gement of DKA only.

Assume 5% deficit in mild/moderate DKA (if pH >7.1)

Assume 10% deficit in severe DKA (if pH <7.1)

Subtract any resuscitation boluses above 20 ml/kg from the total fluid calculation over 48 hours

Initial fluid should be with 0.9% NaCl with potassi um chloride 40 mmol/L if blood glucose > 14 mmol/L

FLUID REQUIREMENT CALCULATION

https://www.bsped.org.uk/media/1380/dka-calc-discla imer.pdf

(see appendix I) 1. If blood glucose level is > 14 mmol/L then use 0.9% NaCl with 40 mmol/L Potassium Chloride 2. If blood glucose level reduces to between 6 - 14 mmol/L

• And ketones ≤ 3 mmol/L change to 0.9% saline + 5% dextrose with KCl 40 mmol/L. Continue insulin at 0.05 Units/kg/h

• If Ketones > 3 mmol/L consider Increasing insulin t o 0.1 Units/kg/h and then change to 0.9% NaCl + 10% Dextrose with KCl 40 mmol/L (Discus s with Diabetes Consultant on call)

3. If blood glucose level reduces to ≤ 6mmol/L, change to 0.9% NaCl + 10% Dextrose with 4 0mmol/L

Potassium Chloride DO NOT STOP INSULIN IF STILL IN DKA

It is useful to write all 3 different bags of fluid s up at the start. Clearly document at what glucose levels each bag of fluid is to run at (as above).

Page 9: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

9

PATIENT LABEL

ADMISSION DAY IMMEDIATE MANAGEMENT DATE……./……./…… .

Time Initial treatment Sign Reason for variance & action taken Sign Commence IVI soluble insulin 50 units

made up to 50 mL with 0.9% NaCl @ 0.05 units/kg/hr

Hourly blood glucose analysis

2-4 hourly U&E and blood gas

1-2 hourly blood ketones

Discuss patient with Consultant

If patient on Lantus/Levemir do not stop whilst on IV insulin

If patient on Insulin pump therapy discontinue this until DKA resolved

INSULIN

CONTINUOUS LOW DOSE INTRAVENOUS INFUSION OF INSULIN IS THE PREFERRED METHOD

Make up a solution of 1 unit per mL of human solubl e insulin (e.g Actrapid) – 50 units made up to 50mL with 0.9% NaCl in a syringe pump. Flush the giving set with 5 mL of insulin infusion as the insulin may be absorbed into the plastic. The solution should run at 0.05 units/kg/hour (0.05 mL/kg/hour) If the blood glucose falls to < 14 mmol/L, add dext rose to the IV fluids. Do not alter the insulin dos e without consulting senior medical staff.

Time Immediate Investigations Sign Reason for variance & action taken Sign Blood glucose analysis

Lab blood glucose

Blood Ketones

HbA1c

Full blood count

Urea and electrolytes

Venous blood gas

Thyroid function

Coeliac screen

Islet cell and GAD antibodies (if new diabetic)

Consider

Urine MC & S � Throat swab �

CXR, � Blood culture �

Other (please specify) �

Page 10: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

10

PATIENT LABEL

Page 11: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

11

PATIENT LABEL

ADMISSION DAY CONTINUED DATE……./……./…….

Time Communication Sign Reason for variance and action taken Sign Explanations given to patient and family

as appropriate

Specific communication needs identified.

Inform porter of impending patient transfer

Inform bleep holder of patient admission bleep 5119

Ensure patient name band and allergy band in situ as appropriate

PLAN FOR PATIENT CAR E AND INFORMATION GIVEN TO PARENTS: (CONTINUE OPPOSITE PAGE IF NECESSARY) Signature:

Dr’s Name (printed): Grade: Bleep No:

Page 12: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

12

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION SIGN

Page 13: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

13

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION SIGN

Page 14: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

14

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION SIGN

Page 15: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

15

PATIENT LABEL

ADMISSION TO WARD DATE……./……./……. Initials required for each shift

Clinical assessments E L N Reason for variance and action taken Sign Secure IVI’s and check sites

Complete hourly fluid balance chart

Measure all urine and chart on fluid balance

Monitor and record blood ketones 1-2 hourly

Monitor and record blood glucose hourly. Inform medical staff if < 6 or > 14 mmol/L or if blood glucose decreasing more than 5mmol/L per hour.

Record and chart hourly observations including O2 saturation respiratory rate and neurological observations.

Consider cardiac monitor

Record waterlow score NB: Consider cerebral oedema if deterioration in neurol ogical observations, heart rate, blood pressure or O2 saturations If blood glucose level reduces to between 6 - 14mmo l/L

1) And ketones ≤ 3 mmol/L change to 0.9% saline + 5% dextrose with KCl 40 mmol/L. Continue insulin at 0.05 Units/kg/h

2) If Ketones > 3 mmol/L consider increasing insuli n to 0.1 Units/kg/h and then change to 0.9% NaCl + 10% Dextrose with KCl 40 mmol/L (Discuss with Diabe tes Consultant on call)

If blood glucose level reduces to ≤ 6mmol/L, change to 0.9% NaCl + 10% Dextrose with 4 0mmol/L Potassium Chloride DO NOT STOP INSULIN UNTIL DKA HAS RESOLVED Initials required for each shift

Hygiene E L N Reason for variance and action taken Sign Continue nil by mouth (may have ice chips)

Give / assist with regular mouth care including teeth cleaning

Regular hygiene Initials required for each shift

Communication E L N Reason for variance and action taken Sign Explain treatment to patient and family as appropriate

Inform diabetes nurse specialist of patients admission

Inform diabetes team of patient admission

Inform dietitian of patient admission

Introduce and inform play specialist as appropriate

Consider giving information pack (If new diabetic)

Page 16: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

16

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 17: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

17

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 18: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

18

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 19: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

19

PATIENT LABEL

Initials required for each shift

DAY TWO DATE……./……./…….

Clinical assessments E L N Reason for variance and action taken Sign Ensure IVI’s secure and check sites

Complete hourly fluid balance chart

Measure all urine and chart on fluid balance

Record 1-2 hourly blood ketones whilst patient on IV insulin infusion

Record hourly blood glucose whilst patient on IV insulin infusion

Change insulin infusion set

If started on SC insulin discontinue neurological observations and commence 4hourly observations of TPR

Record weight

Once DKA has resolved, tolerating oral fluids and ketosis resolving commence SC insulin regimen (new patient): Calculate 0.66u/kg/per day

⅓ to be given as Lantus/ Levemir daily.

⅔ to be given as NovoRapid/ Humalog in 3 equal divided doses with meals

In existing patients commence Novorapid/ Humalog (or Insulin pump) as per previously prescribed doses

Keep IV insulin running for 1 hour after first subcutaneous injection/pump reconnection

Record food eaten (Do not restrict food because of high blood glucose levels).

When IV insulin discontinued, record blood glucose pre-meal and 2 hours post meal, 22:00 and 02:00

Communication E L N Reason for variance and action taken Sign Explain treatment to patient and carer as appropriate

Choose insulin injection pen

Education E L N Reason for variance and action taken Sign Commence education to parent & child

Insulin injection

Blood glucose reading and recording

Ketone testing and recording

Consultation with Dietitian

Discharge E L N Reason for variance and action taken Sign Ensure diabetes information pack given

Order TTO’s

Page 20: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

20

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR DAY TWO SIGN

Page 21: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

21

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 22: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

22

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 23: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

23

PATIENT LABEL

DAY THREE DATE……./……./……. Initials required for each shift

Clinical assessments E L N Reason for variance and action taken Sign Review vital signs

Record blood glucose pre-meal and 2 hours post meal, 22:00 and 02:00

Continue checking blood ketones until negative for ketones

Give NovoRapid / Humalog as prescribed immediately before main meals or immediately post meals.

Do not restrict food because of high blood glucose levels.

Snacks in between meals may be required.

(Low sugar, high carbohydrate healthy eating plan)

Hygiene E L N Reason for variance and action taken Sign Hygiene needs met by patient / carer

Education Sign Reason for variance and action taken Sign Commence education to parent and child as appropriate:

Insulin injection

Blood glucose reading and recording

Ketone testing and recording

Consultation with Dietitian

Communication Sign Reason for variance and action taken Sign Discuss with patient / carer relevant issues / concerns, giving time for parents / carer to ask questions.

Discharge Sign Reason for variance and action taken Sign Ensure diabetes information pack given

Order TTO’s

CONSIDER DISCHARGE IF DISCHARGE CRITERIA MET PAGE.2 9

Page 24: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

24

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR DAY THREE SIGN

Page 25: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

25

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 26: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

26

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 27: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

27

PATIENT LABEL

DAY FOUR DATE……./……./……. Initials required for each shift

Clinical assessments E L N Reason for variance and action taken Sign Patient reviewed by medical staff

Record blood glucose pre-meal and 2 hours post meal, 22:00 and 02:00

Continue urinalysis until negative to ketones

Give NovoRapid / Humalog as prescribed immediately before main meals or immediately post meals.

Do not restrict food because of high blood glucose levels.

Snacks in between meals may be required.

(Low sugar, high carbohydrate healthy eating plan)

Hygiene Sign Reason for variance and action taken Sign Hygiene needs met by patient / carer

Education Sign Reason for variance and action taken Sign Continue education to parent and child as appropriate:

Insulin injection

Blood glucose reading and recording

Ketone testing and recording

Consultation with Dietitian

Communication Sign Reason for variance and action taken Sign Continue discussions with patient / carer over relevant issues / concerns, giving time for parents / carer to ask questions.

Discharge Sign Reason for variance and action taken Sign

CONSIDER DISCHARGE IF DISCHARGE CRITERIA MET (PAGE 31)

Page 28: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

28

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR DAY FOUR SIGN

Page 29: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

29

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 30: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

30

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 31: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

31

PATIENT LABEL

DISCHARGE DATE……./……./…….

INSULIN REGIMEN ON DISCHARGE

Insulin Time

Dose

Clinical assessments Sign Comments Sign

Vital signs within normal parameters

Blood glucose recordings stable

Blood chemistry within normal limits

Patient reviewed by paediatric consultant

Patient reviewed by diabetic nurse specialist

Patient reviewed by dietitian

Discharge plan written

Education Sign Comments Sign

Diabetes information pack given

Appropriate explanation given of condition

Explanation given of diabetes management

Written information of diet plan

Demonstration of insulin pen given to parents/carer and child (if appropriate)

Patient /carer and or child has demonstrated injections and blood glucose testing

Demonstration of blood glucose technique given to parent / carer and child if appropriate

Instruction given as how to document blood glucose

Demonstration given as how to test blood for ketones and significance

Carer / child verbalises understanding of diabetic care and demonstrates ability to provide care.

Appropriate outpatient appointments made

Contact numbers provided

TTOs given to patient/carer and explanation given

Discharge letter given to patient/carer

Page 32: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

32

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR DISCHARGE SIGN

Page 33: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

33

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 34: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

34

PATIENT LABEL

DATE MULTIDISCIPLINARY NOTES FOR ADMISSION TO WARD SIGN

Page 35: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed Febriary 2011 Version 4

35

PATIENT LABEL

Date Time pH pCO2 HCO3

- BE Glucose Lab Na Actual Na See Below*

K Urea Creat CRP TSH fT4 Hb Plt WBC N L Blood Cultures

Urine Culture *Actual Na = (Lab Na+ (Blood Glucose – 5)

3

Results Flow Sheet

Page 36: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed Febriary 2011 Version 4

36

PATIENT LABEL

References & Bibliography Isle of Wight Healthcare NHS Trust (March 2002) Paediatric Ketoacidosis ICP Version 3 Chelsea & Westminster Healthcare NHS Trust Integrated Care Pathway Paediatric Diabetes Dunger,D. et al.(1999) Ketoacidosis; Practical Algorithms in Paediatric Endocrinology Department of Health (April 2003) Getting the right start: National Service Framework for Children Standard for Hospital Services International Society of Paediatric and Adolescent Diabetes (2000)ISPAD Concensus Guidelines for the management of type 1 Diabetes Mellitus in Children and Adolescents http://www.ispad.org/ BSPED Recommended DKA Guidelines. 2009 (Minor review 2013)

Page 37: Integrated Care Pathway PAEDIATRIC DIABETIC KETOACIDOSIS … ICP Aug 2018.pdf · Cerebral oedema is a major cause of mortality and morbidity in children with diabetic ketoacidosis

DKA ICP February 2005 Reviewed May 2018 Version 7

37

PATIENT LABEL

Appendix I

FLUID REQUIREMENT CALCULATION

Maintenance Weight < 10kg give 2 ml/kg/h mL/h Weight 10 – 40 kg give 1 ml/kg/h mL/h Weight > 40 kg fixed volume 40ml/H 40 mL/h Total for 24 hours mL/h

Deficit

% Dehydrated × body weight × 10 mL (Subtract any resuscitation fluid above 20 ml/kg) ml Replaced over 48 hours – divide by 48 for hourly rate ml/h

Total Fluid Calculation

Hourly rate = (deficit/48 hr) + maintenance per ho ur mL/hour